4 Results for "

Lactisole

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Lactisole" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-W030796A
CAS No.: 150436-68-3
Target:  

Taste Receptor

Research Areas:  

Metabolic Disease

Lactisole is a canonical antagonist of sweet taste receptor, selectively targeting to T1R3 subunit, a glucose-sensing receptor. Lactisole inhibits insulin secretion induced by glucose in mouse islets .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-W030796
CAS No.: 13794-15-5
Target:  

Taste Receptor

Research Areas:  

Metabolic Disease

Lactisole free acid is a canonical antagonist of sweet taste receptor, selectively targeting to T1R3 subunit, a glucose-sensing receptor. Lactisole free acid inhibits insulin secretion induced by glucose in mouse islets .
loading...
    loading...
Cat. No.: HY-W030796AR
CAS No.: 150436-68-3
Research Areas:  

Metabolic Disease

Bisdemethoxycucurmin (Standard) is the analytical standard of Bisdemethoxycucurmin. This product is intended for research and analytical applications. Bisdemethoxycucurmin (Curcumin III), a curcuminoid, has antioxidant and antiinflammatory activities .
loading...
    loading...
Cat. No.: HY-W030796R
CAS No.: 13794-15-5
Research Areas:  

Metabolic Disease

Trifluoperazine (dihydrochloride) (Standard) is the analytical standard of Trifluoperazine (dihydrochloride). This product is intended for research and analytical applications. Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis .
loading...
    loading...